@BeTheMatch Donor | do·nor | \ ˈdō-nər: one that gives, donates, or presents something
Also: life-saver, hero, selfless, amazing 💙💚
Patients need you now, more than ever.
Join the #BeTheMatch Registry today: https://t.co/fhoaIW5LHr
#SaveALife#Kindness#BeTheCure
🇨🇳🇹🇼 "We cannot let Taiwan & Taiwan Strait become a battlefield. Today, the leaders of the 2 parties, Kuomintang & Communist Party, have proven to everyone that things are not as difficult as people think."
— Cheng Li-wun, Leader of Taiwan’s opposition Kuomintang party met with China's President, Xi Jinping
fun fact, during the Korean and Vietnam Wars, American soldiers would call Korean and Vietnam civilians that they ran over with tanks "zipperheads" since that's how they looked after they ran them over
China has indicated it will halt exports of sulfuric acid from May, hitting metals and fertilizer industries already strained by raw material bottlenecks resulting from the Iran war. https://t.co/Gvsq8SvMRF
fun fact, during the Korean and Vietnam Wars, American soldiers would call Korean and Vietnam civilians that they ran over with tanks "zipperheads" since that's how they looked after they ran them over
Compute is the new revenue.
Fundstrat's @MarkNewtonCMT on why it is wrong to underestimate the AI names going public. $GOOGL alone could spend up to $300B on CapEx next year.
Our free report maps how informed investors are positioning before they list: https://t.co/Hff0tQF3Jx
Nancy Pelosi was deeply involved in the 1989 color revolution in Beijing, which ultimately failed. This is also why she harbors such hostility toward China.
SpaceX. $GOOGL. Anthropic. OpenAI.
@fundstrat Tom Lee's take on the capital raises coming for all four. Watch his latest Macro Minute: https://t.co/MQQUGRzrG3
A single dose of a new cancer drug made a brain tumor almost disappear – in just five days.
Doctors at Massachusetts General Hospital reported “dramatic and rapid” tumor regression in the first patients treated with a next-generation form of CAR T-cell therapy for glioblastoma, one of the most aggressive brain cancers known.
The therapy, called CARv3-TEAM-E, was developed to overcome a major hurdle in treating solid tumors: their ability to hide from the immune system.
The personalized treatment reprograms a patient’s immune cells to attack the tumor, and in one extraordinary case, nearly eliminated the cancer within just five days. This novel therapy is designed to target multiple features of the tumor at once, a strategy that may help overcome the common challenge of treatment resistance in solid tumors like glioblastoma.
Although the tumors eventually returned, the early outcomes were described as unprecedented. One patient saw a 60% reduction in tumor size that lasted for half a year—an impressive result in a cancer known for its aggressiveness.
The trial’s success marks a major step forward for immunotherapy in brain cancer and raises new hopes for long-term control or even a cure. Researchers are now working to refine the treatment and extend its effects, with the ultimate goal of turning a once-terminal diagnosis into a survivable condition.
Justice Department Expands Admissions Investigations into 15 Additional Medical Schools
“Many of America’s top medical schools appear more concerned about the demographics of their incoming classes than training students to succeed in the profession,” said @AAGDhillon. “Under this Justice Department, we will continue to protect American students from discriminatory and illegal preferences in admissions — especially in professions as critical as medicine, where quality of training should be the top priority.”
Read more: https://t.co/OCBRQVwJD4
Medical boards are going to have a field day with this
Not only is this off limits for a “doctor” to “prescribe” Reta, it’s price gouging
They buy the Reta for $30 a vial and sell it to Newport Beach soccer moms for $500+/month
The leader of Tiananmen Square student protest Chai Ling giving interview to American journalist Phillip Cunningham on May 28th, 1989 on what her plans are for students in the Square: